Welcome to our dedicated page for Cra Intl SEC filings (Ticker: CRAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for CRA International, Inc. (NASDAQ: CRAI), which operates under the trade name Charles River Associates, provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. These documents help investors understand how a global consulting firm specializing in economic, financial, and management consulting services reports its financial condition, operations, and material events.
CRA uses Form 8-K filings to announce items such as quarterly financial results and dividend declarations. For example, recent 8-Ks describe press releases reporting fiscal quarter results and the board of directors’ decisions to declare quarterly cash dividends on common stock. These filings often reference supplemental financial information and prepared remarks made available to investors, giving additional context to the headline numbers.
In addition to current reports, investors typically review annual reports on Form 10-K and quarterly reports on Form 10-Q (when available on this page) to study CRA’s revenue, expenses, and discussion of risks relevant to its consulting business. These periodic reports complement 8-Ks by providing a more detailed view of the company’s operations, including its focus on economic and financial consulting for litigation and regulatory proceedings and its guidance on business strategy and performance-related issues.
Stock Titan enhances access to CRAI filings by pairing raw SEC documents with AI-powered summaries that explain key sections in plain language. Users can quickly identify important points in earnings-related filings, dividend announcements, and other material disclosures without reading every page. Real-time updates from EDGAR help ensure that newly filed CRA International, Inc. documents, including any future Forms 4 related to insider transactions or proxy materials on executive and board matters, are surfaced promptly for further review.
CRA International, Inc. announced a planned board leadership transition. Long-serving director William Concannon will retire from the board following the adjournment of the 2026 Annual Meeting of Shareholders, scheduled for July 16, 2026, after 26 years of service.
Current director Christine Detrick, a board member since 2020 and Chairperson of the Nominating and Corporate Governance Committee, has been appointed to serve as independent Lead Director effective July 16, 2026, subject to her re-election at the Annual Meeting. The company expressed appreciation for Mr. Concannon’s contributions and highlighted Ms. Detrick’s governance experience in a related press release.
The Vanguard Group filed an amended Schedule 13G reporting that it beneficially owns 0 shares of CRA International Inc. (Common Stock), representing 0% of the class. The filing explains an internal realignment on January 12, 2026 that caused certain Vanguard subsidiaries/divisions to report separately.
CRA International EVP and General Counsel Jonathan D. Yellin reported several awards of restricted stock units (RSUs) on March 20, 2026. These RSUs, which include dividend-equivalent units, represent rights to receive shares of CRA International common stock, payable in cash, stock, or a mix after they vest.
The footnotes state that the RSU awards (including dividend units) vest in annual installments beginning on April 11, 2026, April 29, 2026, April 29, 2027, and May 20, 2026, depending on the grant. Following these awards, Yellin also holds nonqualified stock options on 2,377 and 2,845 shares at exercise prices of $44.87 and $47.45, expiring in 2027 and 2028, and 14,702 shares of common stock directly.
Nierenberg Eric reported acquisition or exercise transactions in this Form 4 filing.
CRA International EVP, CFO and Treasurer Eric Nierenberg received a grant of 2.655 restricted stock units (RSUs) tied to the company’s common stock. This is a compensation-related award, not an open-market share purchase or sale.
Each RSU represents a contingent right to receive one share of common stock, which may be settled in cash, shares, or a combination. According to the disclosure, the RSUs, including accumulated dividend-equivalent units, vest in four equal annual installments beginning on August 4, 2026. After this grant, Nierenberg directly holds a total of 740.5654 RSUs.
CRA International, Inc. director and President and CEO Paul A. Maleh reported multiple awards of restricted stock units (RSUs) on 2026-03-20. Each RSU represents a contingent right to receive one share of common stock, payable in cash, stock, or a mix after vesting and tax withholding.
The RSU grants, which include associated dividend equivalent units, vest in equal annual installments beginning on April 11, 2026, April 29, 2026, April 29, 2027, and May 20, 2026, with schedules ranging from two to four years. Following these awards, Maleh holds 115,113 shares of common stock directly, plus nonqualified stock options covering 16,304 shares at an exercise price of $44.8700 expiring on December 18, 2027 and 15,173 shares at $47.4500 expiring on December 6, 2028.
Langan Brian reported acquisition or exercise transactions in this Form 4 filing.
CRA International, Inc. officer Brian Langan reported receiving a grant of 2.655 restricted stock units (RSUs), representing a contingent right to the same number of common shares. After this award, he holds a total of 740.5654 RSUs.
The RSUs, which include dividend-equivalent units, vest in four equal annual installments beginning on August 4, 2026. Vested RSUs may be settled in cash, common stock, or a combination, with any shares delivered shortly after vesting, subject to withholding taxes.
CRA International, Inc. executive Chad M. Holmes reported new equity-based compensation awards rather than market trades. On March 20, 2026, he received several grants of restricted stock units (RSUs), each representing a contingent right to one share of common stock, including associated dividend-equivalent units that vest on future dates beginning in 2026 and 2027. The footnotes state that RSUs, including 25.9023, 45.4824, 17.9637, 22.2730 and 9.7766 dividend units tied to prior awards, will vest in equal annual installments over two to four years. Following these awards, Holmes continues to hold stock options covering 4,076 shares at an exercise price of $44.87 expiring in 2027 and 4,425 shares at $47.45 expiring in 2028, along with 45,920 shares of common stock held directly. The filing reflects routine compensation-related equity grants with no reported open-market buying or selling.
CRA International, Inc. President and CEO Paul A. Maleh reported open-market sales of 7,500 shares of common stock on March 17, 2026 under a pre-arranged Rule 10b5-1 trading plan. The shares were sold at weighted-average prices ranging from about $152.31 to $158.76 per share. Following these transactions, he directly holds 115,113 shares of CRA International common stock.
CRA International proposes sale of common stock. The Form 144 lists a proposed sale of 7,500 shares of Common Stock through Robert W. Baird on 03/17/2026 for trading on Nasdaq. The filing also lists vested PRSUs from 03/01/2019, 03/01/2020, and 03/01/2021 with amounts 3,237, 3,249, and 1,014 respectively.
CRA International, Inc. executive Jonathan D. Yellin reported routine equity compensation activity. On March 10, 2026, he converted restricted stock units into 972.8544 shares of common stock. A portion of these shares was returned to the issuer and withheld at $171.75 per share to cover tax obligations.
After these transactions, Yellin directly holds 14,702 shares of common stock. He also retains multiple unvested restricted stock unit awards tied to common stock, along with nonqualified stock options for 2,377 shares at an exercise price of $44.87 and 2,845 shares at $47.45, expiring in 2027 and 2028 respectively.